HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Margaret A Vizzard Selected Research

Neuropeptide Receptors (Neuropeptide Receptor)

6/2016Intravesical PAC1 Receptor Antagonist, PACAP(6-38), Reduces Urinary Bladder Frequency and Pelvic Sensitivity in NGF-OE Mice.
11/2012Effects of CYP-induced cystitis on PACAP/VIP and receptor expression in micturition pathways and bladder function in mice with overexpression of NGF in urothelium.
11/2010PACAP/VIP and receptor characterization in micturition pathways in mice with overexpression of NGF in urothelium.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Margaret A Vizzard Research Topics

Disease

36Cystitis
01/2022 - 01/2002
27Inflammation (Inflammations)
07/2019 - 02/2005
7Pain (Aches)
07/2019 - 02/2005
7Hypersensitivity (Allergy)
01/2017 - 10/2009
7Abnormal Reflex (Hyperreflexia)
11/2010 - 07/2006
5Spinal Cord Injuries (Spinal Cord Injury)
07/2006 - 07/2002
4Interstitial Cystitis (Interstitial Cystitis, Chronic)
07/2019 - 03/2005
3Weight Loss (Weight Reduction)
11/2014 - 08/2004
2Visceral Pain
07/2019 - 01/2017
2Pelvic Pain
01/2019 - 01/2017
2Neuralgia (Stump Neuralgia)
01/2019 - 01/2017
2Hyperalgesia
01/2019 - 03/2010
2Hyperplasia
01/2018 - 03/2010
2Chronic Pain
01/2017 - 11/2014
2Urinary Incontinence
01/2013 - 01/2011
2Nocturia
01/2013 - 01/2011
1Weight Gain
08/2021
1Herpes Zoster
01/2021
1Underactive Urinary Bladder
12/2018
1Hypertrophy
01/2018
1Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
01/2017
1Urinary Bladder Diseases (Bladder Diseases)
04/2016
1Urinary Retention
01/2013
1Referred Pain
01/2011
1Ganglion Cysts (Ganglion)
11/2010
1Peripheral Nerve Injuries
09/2007
1Pheochromocytoma
09/2007
1Hyperphagia (Overeating)
06/2006

Drug/Important Bio-Agent (IBA)

36Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022 - 01/2002
17Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA
07/2019 - 03/2005
16Nerve Growth Factor (NGF)IBA
01/2022 - 12/2002
8Nerve Growth Factors (Neurotrophins)IBA
01/2022 - 07/2002
8Proteins (Proteins, Gene)FDA Link
08/2016 - 01/2002
7CytokinesIBA
01/2014 - 01/2002
6Messenger RNA (mRNA)IBA
08/2016 - 01/2002
5ChemokinesIBA
01/2018 - 06/2006
4Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022 - 12/2002
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 09/2008
4Adenosine Triphosphate (ATP)IBA
04/2016 - 11/2008
3Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
07/2019 - 11/2008
3Type I Pituitary Adenylate Cyclase-Activating Polypeptide ReceptorsIBA
01/2017 - 11/2008
3Neuropeptide Receptors (Neuropeptide Receptor)IBA
06/2016 - 11/2010
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2016 - 11/2013
3Protein Isoforms (Isoforms)IBA
11/2013 - 09/2008
3Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))IBA
11/2012 - 11/2008
3Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2008 - 12/2002
2Imatinib Mesylate (Gleevec)FDA Link
01/2022 - 01/2022
2Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2019 - 09/2008
2Pharmaceutical PreparationsIBA
01/2018 - 06/2006
2Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
01/2017 - 07/2007
2Growth Factor ReceptorsIBA
08/2016 - 02/2011
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
08/2016 - 01/2002
2Nitric Oxide (Nitrogen Monoxide)FDA Link
04/2016 - 06/2006
2NeuropeptidesIBA
01/2013 - 01/2011
2GalaninIBA
11/2012 - 01/2006
2Interleukin-6 (Interleukin 6)IBA
01/2011 - 01/2002
2Peptides (Polypeptides)IBA
11/2008 - 09/2007
2cobaltiprotoporphyrinIBA
06/2006 - 08/2004
2EnzymesIBA
06/2006 - 03/2004
2Nitric Oxide Synthase Type I (Neuronal Nitric Oxide Synthase)IBA
01/2006 - 03/2004
1CorticosteroneIBA
08/2021
1claudin 8IBA
01/2021
1Claudin-1IBA
01/2021
1Biomarkers (Surrogate Marker)IBA
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1N- (2,4- difluorophenyl)- N'- (4- ((6,7- dimethoxy- 4- quinolyl)oxy)- 2- fluorophenyl)ureaIBA
01/2019
1CollagenIBA
12/2018
1CXC ChemokinesIBA
01/2018
1Ion Channels (Ion Channel)IBA
04/2016
1Cytokine Receptors (Cytokine Receptor)IBA
01/2014
1Chemokine ReceptorsIBA
01/2014
1CCR2 ReceptorsIBA
07/2013
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
07/2013
1diamidino compound 253-50IBA
07/2013
1Antineoplastic Agents (Antineoplastics)IBA
11/2012
1Substance PIBA
11/2012
1Therapeutic UsesIBA
01/2012
1CarrageenanIBA
01/2012
1Dimethyl Sulfoxide (DMSO)FDA LinkGeneric
08/2011
1deguelinIBA
08/2011
1Phosphotransferases (Kinase)IBA
01/2011
1insect maxadilan proteinIBA
11/2010
1Acid Sensing Ion ChannelsIBA
05/2010
1alpha- cyano- (3,4- dihydroxy)- N- benzylcinnamideIBA
10/2009
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
12/2008
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
12/2008
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
11/2008
1Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA
11/2008
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
09/2008
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
08/2007
1Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA
09/2006
1Corticotropin-Releasing HormoneIBA
09/2006
1CX3C Chemokine Receptor 1IBA
06/2006
1Chemokine CX3CL1IBA
06/2006
1protoporphyrin IXIBA
06/2006
1Nitric Oxide Synthase (NO Synthase)IBA
06/2006
1tyrosine receptor kinase A Ig2IBA
03/2005
1Proteinase-Activated ReceptorsIBA
02/2005

Therapy/Procedure

3Intravesical Administration
01/2019 - 04/2006
1Therapeutics
01/2014